Table 5.
Blood testing results
| Donor | Tissue classification | Tissue | Sample ID | Subset | Processing information | sgRNA | gRNA | Mean Ct-GAPDH |
|---|---|---|---|---|---|---|---|---|
| D11 | Blood component | Plasma | D11.05.A | Single sample | No Processing | Negative | Negative | 29.294 |
| D15 | Blood component | Plasma | D15.02.A | Single sample | No Processing | Negative | Negative | 28.541 |
| D15 | Blood component | Serum | D15.03.A | Single sample | No Processing | Negative | Negative | 27.248 |
| D16 | Blood component | Plasma | D16.02.A | Single sample | No Processing | Negative | Negative | 32.780 |
| D16 | Blood component | Serum | D16.03.A | Single sample | No Processing | Negative | Negative | 32.474 |
| D17 | Blood component | Plasma | D17.02.A | Single sample | No Processing | Negative | Negative | 32.904 |
This table provides blood specimen (serum or plasma) results. All samples were tested in quadruplicate for both subgenomic RNA (sgRNA) and genomic nucleocapsid RNA (gRNA) of SARS-CoV-2, and in duplicate for the housekeeping gene Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which served as the positive control